Scientists: Antidepressants Barely Better Than Nothing For Young Patients
The researchers say the quality of evidence about antidepressants and young people is so bad that there's no way to tell if any of them are safe or effective.
The independent source for health policy research, polling, and news.
37,441 - 37,460 of 112,606 Results
The researchers say the quality of evidence about antidepressants and young people is so bad that there's no way to tell if any of them are safe or effective.
OxyContin’s selling point is that it relieves pain for 12 hours, but that is not the case in some patients. Meanwhile the Republican gubernatorial candidate's comments on the opioid crisis rankle law enforcement officers.
Analysts say a merger between Envision Healthcare and AmSurg, which would have a combined value of $9 billion, could increase operating efficiency and profit margins.
Biotechnology Innovation Organization (BIO) President Jim Greenwood says he is seeking to restore the drug industry's reputation, which has taken a hit over high prices. In other industry developments, USA Today reports that the charity-care programs run by three drug makers are drawing scrutiny in two states. Outlets also report on the latest news about Valeant and Glaxo.
It's not clear whether the measure, which was advanced by Rep. Mike Fitzpatrick, R-Pa., and Rep. Louise Slaughter, D-N.Y., will see action this session.
The Senate approved a bill providing $1.1 billion in funding for efforts to combat the virus while the House approved $622 million. The conference committee will try to find a compromise.
Meanwhile, in Iowa, Wellmark will seek a 6 percent increase in premiums for its longtime customers, which is dramatically lower than the rate hike it requested last month for newer customers who gained coverage after the federal health law took effect.
These plans are often cheaper but less comprehensive than those sold on the health law marketplaces. The proposed rules would limit their use to three months.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Although the costs of the drugs are sky high in America, when calculating based on percentage of wealth and cost of living they're more affordable than for other countries such as India and China.
Outlets report on health news from Puerto Rico, Tennessee, Michigan, Texas, Oregon, North Carolina, Ohio, Wisconsin and California.
In other news, a California regional hospital has filed for bankruptcy.
The state promised by 2018 to cover the expensive drugs for all Medicaid patients, rather than just those who were the sickest. Also, a federal judge is considering whether to block Kansas from cutting off Medicaid funding to Planned Parenthood.
A new study suggests that regulators' attempt to predict which people are likely to use a gun to cause harm needs fine-tuning.
In other public health news, the head of the FDA is making a push to get volunteers to turn over their health records for the president's precision medicine initiative, experts say up to 80 percent of eating disorder cases in men can go undiagnosed, scientists suggest primary care doctors start screening for skin cancer, one-third of adults in the U.S. report that they have fair or poor dental health and advocates come out in support of sugary drink warnings.
The region's six governors urge an international conference of physicians to reduce their opioid prescribing. Meanwhile, the FDA warns of overdose risks from a diarrhea drug with opiate-like effects, insurers bet on data to help them fight the epidemic, and the head of the DEA says synthetic designer drugs -- especially opioids -- pose an unprecedented threat to the country.
The studies, however, did not attempt to assess the risk of even a single Olympics traveller carrying the virus back to a vulnerable home country. Meanwhile, media outlets in the states report on the virus.
The researchers focused on searches that indicated someone had been diagnosed with pancreatic cancer. From there, they worked backward, looking for earlier queries that could have shown that the user was experiencing symptoms before the diagnosis.
The test may be able to predict if a patient will respond to the most commonly prescribed medications. In other pharmaceutical news, the Food and Drug Administration eliminates some paperwork doctors must file to access experimental drugs for patients with incurable diseases.
© 2026 KFF